MedTrace Logo

Vivity Outcomes in Patients With Early Stage Glaucoma

NCT04670575 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2024-05-20

No results posted yet for this study

Summary

The goal of the study is to determine the visual outcomes in patients with mild, pre-perimetric glaucoma who undergo cataract surgery with implantation of the Alcon Vivity Extended Range Intraocular Lens (IOL).

Conditions

Interventions

PROCEDURE

Cataract Surgery with Implantation of Vivity Extended Range of Vision IOL

Patients with early stage glaucoma implanted with Vivity or Vivity Toric IOL

Sponsors & Collaborators

  • Vance Thompson Vision

    lead OTHER

Principal Investigators

  • Brian M Shafer, MD · Vance Thompson Vision

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-10-31
Completion
2022-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04670575 on ClinicalTrials.gov